ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Core Insights - ArcStone Securities and Investments Corp. serves as the exclusive financial advisor to Mangoceuticals Inc. in its acquisition of Smokeless Technology Corp., marking Mangoceuticals' entry into the high-growth oral stimulant pouch sector [1][2][3] - The acquisition enhances Mangoceuticals' capabilities in the consumer-packaged goods sector, targeting various demographics including athletes and Gen Z consumers seeking healthier alternatives [3][6] - The transaction is expected to position Mangoceuticals as a leader in the next-generation health and wellness delivery market, leveraging Smokeless Tech's intellectual property and formulations [6][7] Company Overview - Mangoceuticals Inc. is focused on launching high-impact pouches and aims to disrupt traditional wellness delivery methods with "better-for-you" energy solutions [6][7] - The company is set to benefit from the expertise of Tim Corkum, a veteran from Philip Morris International, who will lead the new Pouch Division [4][5] - The acquisition positions Mangoceuticals as one of the few public companies in the functional wellness and oral delivery market, appealing to both institutional and retail investors [8] Strategic Implications - The deal signifies a transformational step for Mangoceuticals, aligning with the trend towards on-the-go, clinically informed wellness solutions [7] - ArcStone's role underscores its expertise in cross-border M&A, particularly in the health and wellness sectors, enhancing its reputation in the financial advisory landscape [3][9] - The combined entity will focus on sourcing disruptive ingredients and proprietary formulations, aiming to lead in the wellness delivery category [6][7]